1 / 25

BY Prof. Mohammad Emam Prof. of OB GYN. Mansoura Faculty of Medicine EGYPT

Pathologic behavior : Non neoplastic Neoplastic (benign,malign, borderline).Morphology(cystic,solid).Histogenesis.. Classification of OV tumours. Ovarian tumours. Neoplastic Epithelial T Germ cell T. Sex cord T others( Metastatic

watson
Télécharger la présentation

BY Prof. Mohammad Emam Prof. of OB GYN. Mansoura Faculty of Medicine EGYPT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. BY Prof. Mohammad Emam Prof. of OB & GYN. Mansoura Faculty of Medicine EGYPT

    2. Pathologic behavior : Non neoplastic Neoplastic (benign,malign, borderline). Morphology(cystic,solid). Histogenesis.

    3. Ovarian tumours Neoplastic Epithelial T Germ cell T. Sex cord T others( Metastatic.)

    4. SEX CORD-STROMAL TUMORS( SCTS)

    5. SEX CORD-STROMAL TUMORS SCTS are 15% of all malignant ovarian neoplasm The vast majority of these tumors are of low malignant potential or benign. Long term prognosis is good. Excessive estrogen production influences end organ responses. Endometrial and breast cancer must be remembered.

    6. SEX CORD-STROMAL TUMORS CLASSIFICATION Granulosa cell tumor Adult Juvenile Thecoma-fibroma Thecoma Fibroma,sarcoma Sclerosing stromal tumor

    7. Granulosa Cell Tumor:

    8. Gonadal Stromal tumours

    9. Metastatic Tumors of Ovary

    12. Krukenberg Tumor:

    13. Endometrioid Ca:

    14. complications of benign ov Tumours torsion hemorrhage rupture infection incarceration malignant change complications during pregnancy

    15. Diagnostic tools History Exam (including rectal) Investigations:- TVS masses and mass characteristics Tumor markers CA-125, LPA (plasma lysophosphatidic acid) CT assess spread to LN, pelvic and abdominal structures MRI best for distinguishing malignant from benign tumors

    16. Clinical picture of benign ov tumors Symptoms: functioning tumors nonfunctioning tumors swelling pressure symptoms pain menstrual disturbances ovarian cachexia Signs small ov tumors large ov tumors DD: from other pelvic swellings from other abdominal swellings

    17. Clinical picture cancer ovary Benign ovarian Tumours + The following suggest malignancy age:mostly postmenopausal pain: chronic and persistent rapid course bilaterality Solidity ( variegated consistency ) fixity metastases :nodules in DP, lymph nodes ascitis edema LL cachexia

    18. Treatment Depends on Staging Tumor type Age Desire for future fertility Include surgery, chemotherapy and/or radiation therapy

    19. Surgery for ov. cancer Conservative surgery: unilateral adnexectomy indicated: stage Ia: intact capsule, negative peritoneal washing, free omentum, well differentiated T, young patient with low parity Complete surgery:TAH/BSO +omentectomy+lymphadenectomy other cases of stage Ia Stage Ib,c

    20. Surgery for ov. Cancer cont Cytoreductive surgery: for all other stages optimum cytoreduction leaving no macroscopic lesion or one less than 1.5 cm. consist of TAH/BSO +omentectomy+lymphadenectomy+may be bowel resection & anastmosis. Second look surgery after chemotherapy

    21. Surgical treatment Primary debulking and cytoreduction; may include: Bilateral salpingo-oopherectomy Hysterectomy Lymphadenectomy (Para-aortic, inguinal) Omentectomy brushing of diaphragm Examination of liver

    22. Chemotherapy & radiotherapy for ov cancer Chemotherapy: adjuvant to surgery to improve prognosis in early stages induce remission in advanced cases agents: alkylating agents,platinum: single drug and multible drug regimens

    23. Chemotherapy & radiotherapy for ov cancer cont Radiotherapy: has less place in modern practice, replaced by chemotherapy was given for cases with small residual lesions (< 2 cm) forms are: radioactive isotope: intraperitoneal 32P , external-beam radiotherapy

    24. Chemotherapy and Radiation Usually 6 cycles of chemotherapy Cisplatin (or Carboplatin) plus Paclitaxel most commonly used combination therapy XRT

More Related